Holocene Advisors, LP Immunocore Holdings PLC Transaction History

Holocene Advisors, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$49.5 - $66.6 $26.2 Million - $35.2 Million	-528,606 Reduced 76.17%	165,357 $8.58 Million
Q2 2023 Aug 14, 2023	SELL	$48.54 - $61.64 $1.55 Million - $1.97 Million	-31,994 Reduced 4.41%	693,963 $41.6 Million
Q1 2023 May 15, 2023	BUY	$46.12 - $65.71 $5.87 Million - $8.36 Million	127,244 Added 21.25%	725,957 $35.9 Million
Q4 2022 Feb 14, 2023	BUY	$45.51 - $65.08 $4.44 Million - $6.35 Million	97,646 Added 19.49%	598,713 $34.2 Million
Q3 2022 Nov 14, 2022	BUY	$37.34 - $57.44 $18.7 Million - $28.8 Million	501,067 New	501,067 $23.5 Million

141

41.4M

197K

451K

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.24B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.